These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37667452)

  • 1. Design and synthesis of benzofuran- and naphthalene-fused thiazinones as antimycobacterial agents.
    Keiff F; Jacques Dit Lapierre TJW; Bernal FA; Kloss F
    Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300356. PubMed ID: 37667452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
    Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1.
    Richter A; Rudolph I; Möllmann U; Voigt K; Chung CW; Singh OMP; Rees M; Mendoza-Losana A; Bates R; Ballell L; Batt S; Veerapen N; Fütterer K; Besra G; Imming P; Argyrou A
    Sci Rep; 2018 Sep; 8(1):13473. PubMed ID: 30194385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Insight into Dearomatization and Decarbonylation of Antitubercular 4H-Benzo[e][1,3]thiazinones: Stable 5H- and 7H-Benzo[e][1,3]thiazines.
    Richter A; Seidel RW; Graf J; Goddard R; Lehmann C; Schlegel T; Khater N; Imming P
    ChemMedChem; 2022 Mar; 17(6):e202200021. PubMed ID: 35170242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
    Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.
    Trefzer C; Škovierová H; Buroni S; Bobovská A; Nenci S; Molteni E; Pojer F; Pasca MR; Makarov V; Cole ST; Riccardi G; Mikušová K; Johnsson K
    J Am Chem Soc; 2012 Jan; 134(2):912-5. PubMed ID: 22188377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
    Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
    Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase.
    Landge S; Mullick AB; Nagalapur K; Neres J; Subbulakshmi V; Murugan K; Ghosh A; Sadler C; Fellows MD; Humnabadkar V; Mahadevaswamy J; Vachaspati P; Sharma S; Kaur P; Mallya M; Rudrapatna S; Awasthy D; Sambandamurthy VK; Pojer F; Cole ST; Balganesh TS; Ugarkar BG; Balasubramanian V; Bandodkar BS; Panda M; Ramachandran V
    Bioorg Med Chem; 2015 Dec; 23(24):7694-710. PubMed ID: 26643218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones.
    Madikizela B; Eckhardt T; Goddard R; Richter A; Lins A; Lehmann C; Imming P; Seidel RW
    Med Chem Res; 2021; 30(8):1523-1533. PubMed ID: 34131377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, in vitro and in silico studies of 2, 3-diaryl benzofuran derivatives as antitubercular agents.
    Bhukya B; Shukla A; Chaturvedi V; Trivedi P; Kumar S; Khan F; Negi AS; Srivastava SK
    Bioorg Chem; 2020 Jun; 99():103784. PubMed ID: 32361184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies of Mycobacterium tuberculosis DprE1 interacting with its inhibitors.
    Piton J; Foo CS; Cole ST
    Drug Discov Today; 2017 Mar; 22(3):526-533. PubMed ID: 27666194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activity.
    Dube PS; Legoabe LJ; Jordaan A; Jesumoroti OJ; Tshiwawa T; Warner DF; Beteck RM
    Eur J Med Chem; 2021 Mar; 213():113207. PubMed ID: 33524688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Predictive Classification Models for Whole Cell Antimycobacterial Activity of Benzothiazinones.
    Schieferdecker S; Bernal FA; Wojtas KP; Keiff F; Li Y; Dahse HM; Kloss F
    J Med Chem; 2022 May; 65(9):6748-6763. PubMed ID: 35502994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents.
    Fan D; Wang B; Stelitano G; Savková K; Shi R; Huszár S; Han Q; Mikušová K; Chiarelli LR; Lu Y; Qiao C
    J Med Chem; 2021 Oct; 64(19):14526-14539. PubMed ID: 34609861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.
    Renuka J; Reddy KI; Srihari K; Jeankumar VU; Shravan M; Sridevi JP; Yogeeswari P; Babu KS; Sriram D
    Bioorg Med Chem; 2014 Sep; 22(17):4924-34. PubMed ID: 25129171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis.
    Richter A; Narula G; Rudolph I; Seidel RW; Wagner C; Av-Gay Y; Imming P
    ChemMedChem; 2022 Mar; 17(6):e202100733. PubMed ID: 34939744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and Efficacy of the Benzothiazinone BTZ-043 against Tuberculous Mycobacteria inside Granulomas in the Guinea Pig Model.
    Eckhardt E; Li Y; Mamerow S; Schinköthe J; Sehl-Ewert J; Dreisbach J; Corleis B; Dorhoi A; Teifke J; Menge C; Kloss F; Bastian M
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0143822. PubMed ID: 36975792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
    Naik M; Humnabadkar V; Tantry SJ; Panda M; Narayan A; Guptha S; Panduga V; Manjrekar P; Jena LK; Koushik K; Shanbhag G; Jatheendranath S; Manjunatha MR; Gorai G; Bathula C; Rudrapatna S; Achar V; Sharma S; Ambady A; Hegde N; Mahadevaswamy J; Kaur P; Sambandamurthy VK; Awasthy D; Narayan C; Ravishankar S; Madhavapeddi P; Reddy J; Prabhakar K; Saralaya R; Chatterji M; Whiteaker J; McLaughlin B; Chiarelli LR; Riccardi G; Pasca MR; Binda C; Neres J; Dhar N; Signorino-Gelo F; McKinney JD; Ramachandran V; Shandil R; Tommasi R; Iyer PS; Narayanan S; Hosagrahara V; Kavanagh S; Dinesh N; Ghorpade SR
    J Med Chem; 2014 Jun; 57(12):5419-34. PubMed ID: 24871036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance.
    Manina G; Bellinzoni M; Pasca MR; Neres J; Milano A; Ribeiro AL; Buroni S; Skovierová H; Dianišková P; Mikušová K; Marák J; Makarov V; Giganti D; Haouz A; Lucarelli AP; Degiacomi G; Piazza A; Chiarelli LR; De Rossi E; Salina E; Cole ST; Alzari PM; Riccardi G
    Mol Microbiol; 2010 Sep; 77(5):1172-85. PubMed ID: 20624223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.